Cargando…
Genome engineering of isogenic human ES cells to model autism disorders
Isogenic pluripotent stem cells are critical tools for studying human neurological diseases by allowing one to study the effects of a mutation in a fixed genetic background. Of particular interest are the spectrum of autism disorders, some of which are monogenic such as Timothy syndrome (TS); others...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4446412/ https://www.ncbi.nlm.nih.gov/pubmed/25765640 http://dx.doi.org/10.1093/nar/gkv164 |
_version_ | 1782373418804445184 |
---|---|
author | Martinez, Refugio A. Stein, Jason L. Krostag, Anne-Rachel F. Nelson, Angelique M. Marken, John S. Menon, Vilas May, Ryan C. Yao, Zizhen Kaykas, Ajamete Geschwind, Daniel H. Grimley, Joshua S. |
author_facet | Martinez, Refugio A. Stein, Jason L. Krostag, Anne-Rachel F. Nelson, Angelique M. Marken, John S. Menon, Vilas May, Ryan C. Yao, Zizhen Kaykas, Ajamete Geschwind, Daniel H. Grimley, Joshua S. |
author_sort | Martinez, Refugio A. |
collection | PubMed |
description | Isogenic pluripotent stem cells are critical tools for studying human neurological diseases by allowing one to study the effects of a mutation in a fixed genetic background. Of particular interest are the spectrum of autism disorders, some of which are monogenic such as Timothy syndrome (TS); others are multigenic such as the microdeletion and microduplication syndromes of the 16p11.2 chromosomal locus. Here, we report engineered human embryonic stem cell (hESC) lines for modeling these two disorders using locus-specific endonucleases to increase the efficiency of homology-directed repair (HDR). We developed a system to: (1) computationally identify unique transcription activator-like effector nuclease (TALEN) binding sites in the genome using a new software program, TALENSeek, (2) assemble the TALEN genes by combining golden gate cloning with modified constructs from the FLASH protocol, and (3) test the TALEN pairs in an amplification-based HDR assay that is more sensitive than the typical non-homologous end joining assay. We applied these methods to identify, construct, and test TALENs that were used with HDR donors in hESCs to generate an isogenic TS cell line in a scarless manner and to model the 16p11.2 copy number disorder without modifying genomic loci with high sequence similarity. |
format | Online Article Text |
id | pubmed-4446412 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-44464122015-06-15 Genome engineering of isogenic human ES cells to model autism disorders Martinez, Refugio A. Stein, Jason L. Krostag, Anne-Rachel F. Nelson, Angelique M. Marken, John S. Menon, Vilas May, Ryan C. Yao, Zizhen Kaykas, Ajamete Geschwind, Daniel H. Grimley, Joshua S. Nucleic Acids Res Methods Online Isogenic pluripotent stem cells are critical tools for studying human neurological diseases by allowing one to study the effects of a mutation in a fixed genetic background. Of particular interest are the spectrum of autism disorders, some of which are monogenic such as Timothy syndrome (TS); others are multigenic such as the microdeletion and microduplication syndromes of the 16p11.2 chromosomal locus. Here, we report engineered human embryonic stem cell (hESC) lines for modeling these two disorders using locus-specific endonucleases to increase the efficiency of homology-directed repair (HDR). We developed a system to: (1) computationally identify unique transcription activator-like effector nuclease (TALEN) binding sites in the genome using a new software program, TALENSeek, (2) assemble the TALEN genes by combining golden gate cloning with modified constructs from the FLASH protocol, and (3) test the TALEN pairs in an amplification-based HDR assay that is more sensitive than the typical non-homologous end joining assay. We applied these methods to identify, construct, and test TALENs that were used with HDR donors in hESCs to generate an isogenic TS cell line in a scarless manner and to model the 16p11.2 copy number disorder without modifying genomic loci with high sequence similarity. Oxford University Press 2015-05-26 2015-03-11 /pmc/articles/PMC4446412/ /pubmed/25765640 http://dx.doi.org/10.1093/nar/gkv164 Text en © The Author(s) 2015. Published by Oxford University Press on behalf of Nucleic Acids Research. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Methods Online Martinez, Refugio A. Stein, Jason L. Krostag, Anne-Rachel F. Nelson, Angelique M. Marken, John S. Menon, Vilas May, Ryan C. Yao, Zizhen Kaykas, Ajamete Geschwind, Daniel H. Grimley, Joshua S. Genome engineering of isogenic human ES cells to model autism disorders |
title | Genome engineering of isogenic human ES cells to model autism disorders |
title_full | Genome engineering of isogenic human ES cells to model autism disorders |
title_fullStr | Genome engineering of isogenic human ES cells to model autism disorders |
title_full_unstemmed | Genome engineering of isogenic human ES cells to model autism disorders |
title_short | Genome engineering of isogenic human ES cells to model autism disorders |
title_sort | genome engineering of isogenic human es cells to model autism disorders |
topic | Methods Online |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4446412/ https://www.ncbi.nlm.nih.gov/pubmed/25765640 http://dx.doi.org/10.1093/nar/gkv164 |
work_keys_str_mv | AT martinezrefugioa genomeengineeringofisogenichumanescellstomodelautismdisorders AT steinjasonl genomeengineeringofisogenichumanescellstomodelautismdisorders AT krostagannerachelf genomeengineeringofisogenichumanescellstomodelautismdisorders AT nelsonangeliquem genomeengineeringofisogenichumanescellstomodelautismdisorders AT markenjohns genomeengineeringofisogenichumanescellstomodelautismdisorders AT menonvilas genomeengineeringofisogenichumanescellstomodelautismdisorders AT mayryanc genomeengineeringofisogenichumanescellstomodelautismdisorders AT yaozizhen genomeengineeringofisogenichumanescellstomodelautismdisorders AT kaykasajamete genomeengineeringofisogenichumanescellstomodelautismdisorders AT geschwinddanielh genomeengineeringofisogenichumanescellstomodelautismdisorders AT grimleyjoshuas genomeengineeringofisogenichumanescellstomodelautismdisorders |